179 related articles for article (PubMed ID: 31871869)
21. Persephin-overexpressing neural stem cells regulate the function of nigral dopaminergic neurons and prevent their degeneration in a model of Parkinson's disease.
Akerud P; Holm PC; Castelo-Branco G; Sousa K; Rodriguez FJ; Arenas E
Mol Cell Neurosci; 2002 Oct; 21(2):205-22. PubMed ID: 12401443
[TBL] [Abstract][Full Text] [Related]
22. Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons.
Choi WS; Kim HW; Tronche F; Palmiter RD; Storm DR; Xia Z
Sci Rep; 2017 Mar; 7():44989. PubMed ID: 28327638
[TBL] [Abstract][Full Text] [Related]
23. The electrophysiological actions of dopamine and dopaminergic drugs on neurons of the substantia nigra pars compacta and ventral tegmental area.
Mercuri NB; Calabresi P; Bernardi G
Life Sci; 1992; 51(10):711-8. PubMed ID: 1355254
[TBL] [Abstract][Full Text] [Related]
24. Stem cell-based therapy for Parkinson's disease.
Correia AS; Anisimov SV; Li JY; Brundin P
Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
[TBL] [Abstract][Full Text] [Related]
25. A novel carbon tipped single micro-optrode for combined optogenetics and electrophysiology.
Budai D; Vizvári AD; Bali ZK; Márki B; Nagy LV; Kónya Z; Madarász D; Henn-Mike N; Varga C; Hernádi I
PLoS One; 2018; 13(3):e0193836. PubMed ID: 29513711
[TBL] [Abstract][Full Text] [Related]
26. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
27. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ
Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250
[TBL] [Abstract][Full Text] [Related]
28. Sensitive detection of electrophysiology and dopamine vesicular exocytosis of hESC-derived dopaminergic neurons using multifunctional microelectrode array.
He E; Zhou Y; Luo J; Xu S; Zhang K; Song Y; Wang M; Xu S; Dai Y; Yang G; Xie J; Xu Z; Zhu W; Deng Y; Xu Q; Cai X
Biosens Bioelectron; 2022 Aug; 209():114263. PubMed ID: 35483214
[TBL] [Abstract][Full Text] [Related]
29. Investigating the Influence of GABA Neurons on Dopamine Neurons in the Ventral Tegmental Area Using Optogenetic Techniques.
Ohta Y; Murakami TE; Kawahara M; Haruta M; Takehara H; Tashiro H; Sasagawa K; Ohta J; Akay M; Akay YM
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163036
[TBL] [Abstract][Full Text] [Related]
30. Amperometric Monitoring of Sensory-Evoked Dopamine Release in Awake Larval Zebrafish.
Shang CF; Li XQ; Yin C; Liu B; Wang YF; Zhou Z; Du JL
J Neurosci; 2015 Nov; 35(46):15291-4. PubMed ID: 26586817
[TBL] [Abstract][Full Text] [Related]
31. Efficient generation of dopaminergic neurons from mouse embryonic stem cells enclosed in hollow fibers.
Yamazoe H; Iwata H
Biomaterials; 2006 Oct; 27(28):4871-80. PubMed ID: 16766027
[TBL] [Abstract][Full Text] [Related]
32. Reversal of dopaminergic degeneration in a parkinsonian rat following micrografting of human bone marrow-derived neural progenitors.
Glavaski-Joksimovic A; Virag T; Chang QA; West NC; Mangatu TA; McGrogan MP; Dugich-Djordjevic M; Bohn MC
Cell Transplant; 2009; 18(7):801-14. PubMed ID: 19796495
[TBL] [Abstract][Full Text] [Related]
33. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
Chen W; Huang Q; Ma S; Li M
ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
[TBL] [Abstract][Full Text] [Related]
34. Attenuated dopaminergic neurodegeneration and motor dysfunction in hemiparkinsonian mice lacking the α5 nicotinic acetylcholine receptor subunit.
Leino S; Koski SK; Hänninen R; Tapanainen T; Rannanpää S; Salminen O
Neuropharmacology; 2018 Aug; 138():371-380. PubMed ID: 29940207
[TBL] [Abstract][Full Text] [Related]
35. Long term behavioral effects of functional dopaminergic neurons generated from human neural stem cells in the rat 6-OH-DA Parkinson's disease model. Effects of the forced expression of BCL-X(L).
Ramos-Moreno T; Castillo CG; Martínez-Serrano A
Behav Brain Res; 2012 Jun; 232(1):225-32. PubMed ID: 22537773
[TBL] [Abstract][Full Text] [Related]
36. One year survival and significant reversal of motor deficits in parkinsonian rats transplanted with hESC derived dopaminergic neurons.
Geeta R; Ramnath RL; Rao HS; Chandra V
Biochem Biophys Res Commun; 2008 Aug; 373(2):258-64. PubMed ID: 18565328
[TBL] [Abstract][Full Text] [Related]
37. Bioluminescence-driven optogenetic activation of transplanted neural precursor cells improves motor deficits in a Parkinson's disease mouse model.
Zenchak JR; Palmateer B; Dorka N; Brown TM; Wagner LM; Medendorp WE; Petersen ED; Prakash M; Hochgeschwender U
J Neurosci Res; 2020 Mar; 98(3):458-468. PubMed ID: 29577367
[TBL] [Abstract][Full Text] [Related]
38. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
39. Electrochemical Detection of Dopamine Release from Living Neurons Using Graphene Oxide-Incorporated Polypyrrole/Gold Nanocluster Hybrid Nanopattern Arrays.
Cho YW; Park JH; Kang MJ; Lee JH; Kim YK; Luo Z; Kim TH
Small; 2023 Dec; 19(52):e2304271. PubMed ID: 37649209
[TBL] [Abstract][Full Text] [Related]
40. Protective action of recombinant neurturin on dopaminergic neurons in substantia nigra in a rhesus monkey model of Parkinson's disease.
Li H; He Z; Su T; Ma Y; Lu S; Dai C; Sun M
Neurol Res; 2003 Apr; 25(3):263-7. PubMed ID: 12739234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
